GSK (GSK) reported better-than-expected financials for Q1 2026 on Wednesday as sales from its HIV and cancer medicines offset a sales decline for its general medicines, including its respiratory ...
GSK Plc is planning five simultaneous late-stage trials for a cancer drug it hopes will be a blockbuster, as new Chief Executive Officer Luke Miels tries to revitalize a company not known for its risk ...
Fluticasone Propionate, an authorized generic version of asthma medication Flovent, sits on a table in nasal spray form. (Photo by _bubby_, CC BY 2.0, via Courthouse News) PHOENIX (CN) — ...
GSK (GSK) announced on Thursday that the U.S. FDA approved Lynavoy as a treatment for an itching condition called cholestatic pruritus associated with primary biliary cholangitis (PBC), a rare ...
DEALING WITH A DIFFICULT SITUATION, OR EVEN JUST BEFORE GOING HOME. A LOW COST ALTERNATIVE FOR COMMONLY USED ASTHMA MEDICATION WILL ENTER THE MARKET AFTER PRESSURE FROM SENATOR MAGGIE HASSAN ...
More than 20 years after gaining FDA approval for Flovent, GSK still controlled the market in the U.S. for the asthma inhaler through a partnership with an “authorized generic” dealer, a setup that ...
After GSK replaced a popular asthma inhaler with an identical product at a much higher price in order to avoid paying Medicaid rebates, many families reported substantial financial and treatment ...
Since discontinuing its two branded versions of asthma inhaler Flovent at the start of 2024, GSK has still produced “authorized generic” versions of the treatment, which are the same products with ...
GSK struck a $950 million deal to buy Canada’s 35Pharma, a biopharmaceutical company developing cardiopulmonary treatments, as the U.K. drugmaker seeks to bolster its exposure to diseases linked to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results